Cargando…
Molecular targets and signaling pathways regulated by interleukin (IL)-24 in mediating its antitumor activities
Cancer remains a major health issue in the world and the effectiveness of current therapies is limited resulting in disease recurrence and resistance to therapy. Therefore to overcome disease recurrence and have improved treatment efficacy there is a continued effort to develop and test new anticanc...
Autores principales: | Panneerselvam, Janani, Munshi, Anupama, Ramesh, Rajagopal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3879428/ https://www.ncbi.nlm.nih.gov/pubmed/24377906 http://dx.doi.org/10.1186/1750-2187-8-15 |
Ejemplares similares
-
Phosphorylation of interleukin (IL)-24 is required for mediating its anti-cancer activity
por: Panneerselvam, Janani, et al.
Publicado: (2015) -
IL-24 Inhibits Lung Cancer Growth by Suppressing GLI1 and Inducing DNA Damage
por: Panneerselvam, Janani, et al.
Publicado: (2019) -
IL-24 modulates the high mobility group (HMG) A1/miR222 /AKT signaling in lung cancer cells
por: Panneerselvam, Janani, et al.
Publicado: (2016) -
HuR-targeted nanotherapy in combination with AMD3100 suppresses CXCR4 expression, cell growth, migration, and invasion in lung cancer
por: Muralidharan, Ranganayaki, et al.
Publicado: (2015) -
YAP1 inhibition radiosensitizes triple negative breast cancer cells by targeting the DNA damage response and cell survival pathways
por: Andrade, Daniel, et al.
Publicado: (2017)